Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P Futures
6,002.75
-1.00(-0.02%)
Dow Futures
43,902.00
-8.00(-0.02%)
Nasdaq Futures
21,225.25
+0.50(+0.00%)
Russell 2000 Futures
2,397.40
+1.70(+0.07%)
Crude Oil
71.84
-0.52(-0.72%)
Gold
2,704.50
-1.30(-0.05%)

Oxford Biomedica plc (OXB.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)

Follow

417.00

+1.50

(+0.36%)

At close: 06:36PM GMT

Currency in GBp

Valuation Measures⁴

Market Cap (intraday)	440.11M
Enterprise Value	469.00M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	4.31
Price/Book (mrq)	6.64
Enterprise Value/Revenue	4.82
Enterprise Value/EBITDA	-819.73

Trading Information

Stock Price History

Beta (5Y Monthly)	1.05
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	450.00
52 Week Low ³	164.29
50-Day Moving Average ³	374.95
200-Day Moving Average ³	297.92

Share Statistics

Avg Vol (3 month) ³	154.54k
Avg Vol (10 day) ³	207k
Shares Outstanding ⁵	105.92M
Implied Shares Outstanding ⁶	N/A
Float ⁸	69.08M
% Held by Insiders ¹	21.05%
% Held by Institutions ¹	65.24%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:50
Last Split Date ³	May 30, 2018

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	-145.98%
Operating Margin (ttm)	-60.50%

Management Effectiveness

Return on Assets (ttm)	-12.67%
Return on Equity (ttm)	-124.66%

Income Statement

Revenue (ttm)	97.28M
Revenue Per Share (ttm)	0.96
Quarterly Revenue Growth (yoy)	18.00%
Gross Profit (ttm)	N/A
EBITDA	-55.94M
Net Income Avi to Common (ttm)	-142.02M
Diluted EPS (ttm)	-1.44
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	81.41M
Total Cash Per Share (mrq)	0.77
Total Debt (mrq)	110.31M
Total Debt/Equity (mrq)	154.88
Current Ratio (mrq)	2.35
Book Value Per Share (mrq)	0.63

Cash Flow Statement

Operating Cash Flow (ttm)	-62.3M
Levered Free Cash Flow (ttm)	-34.93M